Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 11:50AM ET
51.76
Dollar change
+0.42
Percentage change
0.83
%
IndexS&P 500 P/E13.42 EPS (ttm)3.86 Insider Own0.09% Shs Outstand2.02B Perf Week4.68%
Market Cap104.66B Forward P/E7.26 EPS next Y7.13 Insider Trans-0.24% Shs Float2.02B Perf Month3.02%
Income8.03B PEG- EPS next Q1.62 Inst Own78.47% Short Float1.54% Perf Quarter6.76%
Sales45.01B P/S2.33 EPS this Y-8.51% Inst Trans-0.74% Short Ratio2.01 Perf Half Y-15.93%
Book/sh14.56 P/B3.55 EPS next Y3.82% ROA8.36% Short Interest31.09M Perf Year-27.42%
Cash/sh6.10 P/C8.48 EPS next 5Y-3.40% ROE26.53% 52W Range47.58 - 71.98 Perf YTD0.87%
Dividend Est.2.46 (4.74%) P/FCF8.27 EPS past 5Y5.14% ROI11.87% 52W High-28.10% Beta0.38
Dividend TTM2.31 (4.46%) Quick Ratio1.31 Sales past 5Y16.92% Gross Margin56.34% 52W Low8.77% ATR (14)1.10
Dividend Ex-DateJan 04, 2024 Current Ratio1.43 EPS Y/Y TTM30.29% Oper. Margin18.78% RSI (14)64.40 Volatility2.28% 2.20%
Employees34100 Debt/Eq1.41 Sales Y/Y TTM-2.50% Profit Margin17.83% Recom2.71 Target Price55.42
Option/ShortYes / Yes LT Debt/Eq1.30 EPS Q/Q-8.96% Payout59.82% Rel Volume0.64 Prev Close51.33
Sales Surprise2.54% EPS Surprise9.42% Sales Q/Q0.62% EarningsFeb 02 BMO Avg Volume15.44M Price51.76
SMA204.77% SMA502.66% SMA200-9.70% Trades Volume3,872,702 Change0.83%
Date Action Analyst Rating Change Price Target Change
Feb-06-24Downgrade Redburn Atlantic Buy → Neutral $77 → $54
Jan-03-24Downgrade BofA Securities Buy → Neutral $68 → $60
Nov-15-23Downgrade Cantor Fitzgerald Overweight → Neutral $68 → $55
Nov-09-23Initiated Deutsche Bank Hold $55
Nov-02-23Downgrade Daiwa Securities Outperform → Neutral $68 → $54
Oct-27-23Upgrade HSBC Securities Reduce → Hold $55 → $53
Oct-27-23Downgrade William Blair Outperform → Mkt Perform
Oct-27-23Downgrade BMO Capital Markets Outperform → Market Perform $60
Oct-20-23Resumed UBS Neutral $70 → $60
Jul-14-23Initiated HSBC Securities Reduce $56
Today 06:59AM
06:59AM
Feb-22-24 07:00AM
Feb-20-24 06:59AM
06:30AM
07:57PM Loading…
Feb-14-24 07:57PM
04:16PM
08:30AM
06:59AM
Feb-12-24 06:59AM
Feb-07-24 08:55AM
06:59AM
Feb-05-24 09:20AM
06:59AM
Feb-03-24 08:49AM
11:37AM Loading…
Feb-02-24 11:37AM
10:58AM
07:26AM
06:59AM
Feb-01-24 05:23PM
09:29AM
05:30AM
Jan-30-24 09:15AM
06:59AM
Jan-27-24 10:00AM
Jan-26-24 07:13AM
Jan-23-24 08:30AM
Jan-22-24 05:05PM
05:00PM
Jan-20-24 10:00AM
02:41PM Loading…
Jan-18-24 02:41PM
Jan-17-24 06:59AM
Jan-10-24 04:15PM
Jan-08-24 08:37PM
Jan-02-24 06:59AM
Dec-27-23 07:04PM
12:13PM
09:39AM
Dec-26-23 03:31PM
02:34PM
12:33PM
11:47AM
11:42AM
09:23AM
09:00AM
07:13AM
Dec-22-23 03:44PM
01:26PM
09:46AM
09:31AM
09:13AM
07:05AM
06:59AM
06:32AM
Dec-20-23 04:16PM
Dec-15-23 05:22PM
04:54PM
06:59AM
Dec-14-23 07:00AM
Dec-12-23 03:07PM
Dec-11-23 09:00PM
08:30PM
07:30PM
05:13PM
04:27PM
04:15PM
Dec-10-23 09:26PM
01:48PM
11:40AM
Dec-09-23 05:00PM
Dec-08-23 05:45PM
12:21PM
Dec-07-23 11:35AM
06:59AM
06:30AM
Dec-06-23 04:16PM
11:13AM
10:02AM
09:43AM
Dec-05-23 11:23AM
11:15AM
06:59AM
Dec-01-23 01:56PM
07:05AM
03:00AM
Nov-30-23 08:02AM
Nov-28-23 02:51PM
10:02AM
07:01AM
06:30AM
Nov-26-23 06:51AM
Nov-24-23 05:30AM
Nov-23-23 04:47PM
Nov-22-23 04:01PM
09:09AM
05:04AM
Nov-21-23 10:15AM
Nov-20-23 04:55PM
04:48PM
03:16PM
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Feb 01Option Exercise0.002,54306,040Feb 05 07:10 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerDec 05Buy49.782,00099,56082,672Dec 07 06:06 PM
Plenge Robert MEVP, Chief Research OfficerDec 02Option Exercise0.0061607,200Dec 05 06:23 PM
Elkins David VEVP, Chief Financial OfficerDec 02Option Exercise0.008,7920172,342Dec 05 06:22 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerDec 02Option Exercise0.002,638082,022Dec 05 06:21 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerNov 28Buy48.863,071150,04979,384Nov 30 06:32 PM
Samuels Theodore R. IIDirectorNov 20Buy49.818,500423,38535,500Nov 21 07:01 PM
Powell AnnEVP, Chief Human ResourcesAug 24Sale61.2517,9861,101,64227,868Aug 28 05:28 PM
Plenge Robert MEVP, Chief Research OfficerAug 03Sale61.1473244,7546,584Aug 07 05:24 PM
Weese MichelleEVP, Corporate AffairsJul 01Option Exercise0.001,88504,135Jul 05 05:26 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Jul 01Option Exercise0.009,357052,032Jul 05 05:23 PM
Lenkowsky AdamEVP, Chief Commercial OfficerJun 03Option Exercise0.001,07701,077Jun 06 07:39 PM
VESSEY RUPERTEVP & President, ResearchMay 03Sale67.0650,3853,378,81847,751May 04 05:51 PM
Greenlees SharonSVP & ControllerMay 02Option Exercise0.001,0170728May 03 07:36 PM
Mily ElizabethEVP, Strategy & BDApr 01Option Exercise0.006,346035,873Apr 04 08:40 PM
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyApr 01Option Exercise0.003,30604,918Apr 04 08:40 PM
Mily ElizabethEVP, Strategy & BDMar 10Option Exercise0.0029,636038,173Mar 14 08:40 PM
VESSEY RUPERTEVP & President, ResearchMar 10Option Exercise0.0066,9350118,263Mar 14 08:34 PM
LEUNG SANDRAEVP, General CounselMar 10Option Exercise0.0057,9900356,920Mar 14 08:28 PM
Powell AnnEVP, Chief Human ResourcesMar 10Option Exercise0.0034,447053,100Mar 14 08:18 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Mar 10Option Exercise0.0038,978054,035Mar 14 08:18 PM
Weese MichelleEVP, Corporate AffairsMar 10Option Exercise0.001,59002,793Mar 14 08:14 PM
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyMar 10Option Exercise0.002,44702,447Mar 14 08:12 PM
Caforio GiovanniBoard Chair and CEOMar 10Option Exercise0.00234,6760431,381Mar 14 08:13 PM
Elkins David VEVP, Chief Financial OfficerMar 10Option Exercise0.0071,8710185,308Mar 14 08:13 PM
BOERNER CHRISTOPHER S.EVP, Chief Commercial OfficerMar 10Option Exercise0.0059,111091,880Mar 14 08:13 PM
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Mar 10Option Exercise0.002,83604,648Mar 14 08:14 PM